Reckitt Benckiser Group (LON:RKT) Stock Rating Reaffirmed by JPMorgan Chase & Co.

Reckitt Benckiser Group (LON:RKTGet Rating)‘s stock had its “overweight” rating reaffirmed by analysts at JPMorgan Chase & Co. in a report released on Wednesday, Marketbeat Ratings reports.

Other research analysts also recently issued research reports about the stock. Barclays reissued an “overweight” rating and set a GBX 9,300 ($113.91) price objective on shares of Reckitt Benckiser Group in a report on Friday, May 20th. Morgan Stanley restated an “overweight” rating on shares of Reckitt Benckiser Group in a report on Wednesday, May 11th. Royal Bank of Canada reaffirmed an “outperform” rating and set a GBX 7,000 ($85.74) price objective on shares of Reckitt Benckiser Group in a report on Wednesday, June 1st. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 7,200 ($88.19) target price on shares of Reckitt Benckiser Group in a report on Thursday, May 26th. Finally, Berenberg Bank upped their price target on shares of Reckitt Benckiser Group from GBX 7,460 ($91.38) to GBX 7,700 ($94.32) and gave the company a “buy” rating in a research note on Friday, April 29th. Seven investment analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of GBX 7,685.71 ($94.14).

RKT opened at GBX 6,028 ($73.84) on Wednesday. The company has a debt-to-equity ratio of 129.26, a quick ratio of 0.40 and a current ratio of 0.62. The stock has a market capitalization of £43.12 billion and a price-to-earnings ratio of -1,338.67. The company has a fifty day moving average of GBX 6,181.97 and a 200 day moving average of GBX 6,106.05. Reckitt Benckiser Group has a fifty-two week low of GBX 4,905.16 ($60.08) and a fifty-two week high of GBX 6,604 ($80.89).

In related news, insider Laxman Narasimhan sold 7,713 shares of the stock in a transaction on Friday, May 20th. The stock was sold at an average price of GBX 6,214 ($76.11), for a total transaction of £479,285.82 ($587,072.29).

About Reckitt Benckiser Group (Get Rating)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Further Reading

Analyst Recommendations for Reckitt Benckiser Group (LON:RKT)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.